HOME >> BIOLOGY >> NEWS
Chronic pain: treatment, rehabilitation, and quality of life

The current issue of the Journal of Rehabilitation Research and Development (JRRD), a publication of Rehabilitation Research and Development, Department of Veterans Affairs (VA), includes a special section that focuses on the treatment, rehabilitation, and quality of life for individuals who experience chronic pain. Also in this issue are articles that report on structuring exercise for people with motion-provoked dizziness, improving arm movement with functional electrical stimulation, and predicting wound healing in individuals with spinal cord injury.

Also published with Volume 40 Issue 5 of JRRD is a supplement addressing chronic obstructive pulmonary disease (COPD). The only major chronic disease with increasing mortality, COPD places a significant strain on the healthcare system. This special edition highlights three critical outcomes of pulmonary rehabilitation: smoking cessation, symptom relief, and improved functional performance. Full-text manuscripts for both issues of JRRD are available, free of charge, on-line at www.vard.org.

MANUSCRIPTS FEATURED IN VOL. 40, IS. 5

Development and validation of a pain management survey, pg # 381
Paper presents the development and validation of a comprehensive and efficient self-report measure of pain treatment outcomes. 957 veterans receiving inpatient and outpatient pain treatment at six VA medical centers completed the Pain Outcomes Questionnaire-VA (POQ-VA) intake items during their inpatient admission or initial outpatient appointment. Results of this project support the reliability, validity, and clinical use of the POQ-VA for evaluating the effectiveness of pain treatment for veterans experiencing chronic noncancer pain and provide a more appropriate means of evaluating the efficacy of pain interventions.

Pain and associations with health and the healthcare system, pg 371
Study reports on the prevalence of pain am
'"/>

Contact: Judith LaVoie
Judith@vard.org
410-962-1800 x 229
VA Research Communications Service
30-Sep-2003


Page: 1 2 3 4

Related biology news :

1. Chronic respiratory symptoms prevalent among Alaska natives
2. Chronic alcohol abuse damages regulating hormones
3. Chronic stress affects more than fertility, Magee-Womens Research Institute study finds
4. Chronic Lyme disease symptoms not helped by intensive antibiotic treatment
5. Slimy Bacteria Common Cause Of Chronic Infections
6. For First Time In 40 Years National Jewish Researchers Report Chronic Beryllium Disease Caused By Extremely Low Levels Of Exposure
7. Bacteria From Gum Infections Associated With Diabetes, Chronic Lung Disease, UB Studies Find
8. Immunex And Wyeth-Ayerst Laboratories Advance Enbrel Into Phase II/III Clinical Trial For Chronic Heart Failure
9. New Hypothesis Proposed For Cause Of Chronic Fatigue Syndrome
10. Learning To Feel Chronic Pain
11. Jefferson Scientists Devise Way To Treat Animals Chronically Infected With Hepatitis B

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Chronic pain treatment rehabilitation and quality life

(Date:10/22/2014)... Medicine® scientists helps explain how bipolar disorder affects the ... therapies to treat the mental illness. , Scientists ... method recognized with the 2014 Nobel Prize in ... from mice with bipolar-like behaviors. In the synapses (where ... structures with concentrated levels of ANK3 -- the gene ...
(Date:10/22/2014)... , Oct. 20, 2014  Leading identity analyst firm ... half of the world,s population will have a chip-based ... Europe . Asia , ... market accounting for more than 60% of all National ... Acuity,s report  -- "The Global National eID ...
(Date:10/19/2014)... in India over the last 30 years contributed ... growth during that time, according to a new ... Change ., "Energy access is fundamental to development: ... including education, communication, and health," says IIASA researcher ... increased energy access is widely agreed to be ...
Breaking Biology News(10 mins):Bipolar disorder discovery at the nano level 2Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Improved electricity access has little impact on climate change 2
(Date:10/25/2014)... , October 24, 2014 ... Corporation (NASDAQ: CYTR ), Vertex Pharmaceuticals Inc. ... ALXN ), Peregrine Pharmaceuticals Inc. (NASDAQ: ... research on these five companies can be accessed at: ... Thursday, October 23, 2014, ended on a positive note ...
(Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis ... specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today ... to acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., ... for the treatment of diabetic gastroparesis and other GI ... successful Phase 2 trial of relamorelin for the treatment ...
(Date:10/22/2014)... WriteResult, LLC – a premier provider of ... a team of researchers from Yale University’s School of ... to provide electronic questionnaire data collection through use of ... in May, aims to evaluate the impact of a ... and participation in urban agriculture to impact their consumption ...
(Date:10/22/2014)... ROCKVILLE, Md. , Oct. 22, 2014   ... company developing novel pathogen-specific therapies for serious infections and ... Office has issued a Notice of Allowance for a ... product in its C. difficile program, SYN-004. This ... to SYN-004 in the U.S. and adds to the ...
Breaking Biology Technology:Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4
Cached News: